NEEDLES MARKET ANALYSIS

Needles Market, By Needles Type (Conventional Needless and Safety Needless), By Delivery Site (Intradermal, Subcutaneous, Intravenous, Intramuscular, and Intraperitoneal), By Application (Surgical Suture Needless, Pen Needless in Diabetes, Blood Collection Needless, Ophthalmic Procedure Needless, Dentistry Needless, Insufflation Needless, and Other Needless), By Material (Stainless Steel Needless, Plastic Needless, Glass Needless, and PEEK Needless), By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

Recent Developments:

New product launches & Approval:

On October 13, 2023, Rhythmlink International, LLC, a medical device company, launched a new product family, concentric needles. The concentric needle is offered in four sizes or gauges, which also vary in needle diameter, length and color, matching the accepted workflows.
In September 2022, Serpex Medical announced U.S. FDA 510(k) clearance of its Compass Steerable Needless – steerable biopsy needles that enable precise access to lung nodules in the intrapulmonary region to improve the diagnosis and treatment of lung cancer. The clearance of the compass steerable needles follows the clearance of Serpex\'s Recon Steerable Sheath.
In May 2022, Roche Diabetes Care, a global leader in integrated personalized diabetes management (iPDM), launched Accu-Fine, quality pen needles to make the process of insulin delivery smoother and virtually painless for people with diabetes. This latest innovation from (Roche Diabetes Care, maker of Accu-Chek) the house of Accu-Chek aims to make the process of insulin delivery easier thereby leading to better diabetes management for people with diabetes.

Acquisition, Collaboration and Partnerships:

On September 26, 2023, Sharps Technology, Inc., an innovative medical device and pharmaceutical packaging company and Nephron Pharmaceuticals Corporation, a privately owned U.S. leader in contract manufacturing and 503B outsourcing, announce the signing of an Asset Purchase Agreement (APA) to acquire Nephron’s InjectEZ specialty syringe manufacturing facility. This includes a purchase agreement for over US$ 400 Mn from Nephron Pharmaceuticals for next-generation copolymer prefillable syringe systems.
In January 2022, ICU Medical Inc., a medical device company, announced acquisition of Smiths Medical, a medical device company. Smiths Medical business includes syringe and ambulatory infusion devices, vascular access, and vital care products.